Skip to main content
Premium Trial:

Request an Annual Quote

Celera Licenses Databases to Europe s Largest Biotech Firm

NEW YORK, Dec. 20 - Celera Genomics has licensed its genomic databases to Serono, Europe's largest biotech firm, Celera said on Thursday.

 

Financial terms of the multi-year subscription agreement were not disclosed.

 

"This agreement is another important element in our expanding genomics program," said Silvano Fumero, senior executive vice president for research and pharmaceutical development at Serono. He added that the Applera unit's mouse and human genome sequences "will support Serono's scientific efforts to discover novel targets and therapeutic proteins."

 

Serono, considered the third-largest biotech in the world in revenue, is based in Geneva.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.